It is a chemicals private limited company based in New Delhi, Delhi, India, established in 2022.
2022 | New Delhi, Delhi, India | ActiveSolivare Pharma Private Limited, a active private limited company, was established on 03 March 2022 in New Delhi, Delhi, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24239DL2022PTC394585. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Atul Kumar (Additional Director), Sujit Kumar Singh (Additional Director). Past directors included Sujeet Kumar Jha, Nibha Thakur, Vicky Kumar Sah. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No-35 Basement Block C South Extn Ii, New Delhi, Delhi, 110049.
U24239DL2022PTC394585
394585
03 March 2022
₹1.50 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Solivare Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Atul Kumar | Additional Director | 27 Apr 2023 | Current |
| Sujit Kumar Singh | Additional Director | 20 May 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 28 Apr 2023 | Past |
| Pramod Abcsdd | Director | 12 Aug 2023 | Past |
| Pramod Abcsdd | Additional Director | 20 May 2025 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Solivare Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Solivare Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Solivare Pharma has a workforce of 0 employees as of Mar 21, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Solivare Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Solivare Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Sujit Kumar Singh was appointed as a Additional Director was appointed as a Additional Director on 20 May 2025 & has been associated with this company since 7 months 7 days . was recorded as a recent event.
Progress on Solivare Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Solivare Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
The activity Atul Kumar was appointed as a Additional Director was appointed as a Additional Director on 27 Apr 2023 & has been associated with this company since 2 years 8 months . was completed.
Solivare Pharma Private Limited was registered on 03 Mar 2022 with Roc Delhi & aged 3 years 9 months as per MCA records. was recorded as a recent event.
The CIN of Solivare Pharma Private Limited is U24239DL2022PTC394585.
Solivare Pharma Private Limited is headquartered at Plot No-35 Basement Block C South Extn Ii, New Delhi, Delhi, 110049.
Solivare Pharma Private Limited was incorporated on 03 March 2022.
The current directors of Solivare Pharma Private Limited are
The primary industry of Solivare Pharma Private Limited is Chemicals.
Solivare Pharma Private Limited is unlisted.
The authorized capital of Solivare Pharma Private Limited is ₹1.50 M, and the paid-up capital is ₹0.10 M.
The compliance status of Solivare Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX